CITADEL ADVISORS LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Lyra Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares") (LYRA)

Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Citadel Advisors LLC
Security
Lyra Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares")
Symbol
LYRA
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 18:22:42 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 0% 0 0 0 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 0% 0 0 0 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 0% 0 0 0 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0% 21.1K 0 21.1K /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities Group LP 0% 21.1K 0 21.1K /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities GP LLC 0% 21.1K 0 21.1K /s/ Guy Miller Guy Miller, Authorized Signatory
Kenneth Griffin 0% 21.1K 0 21.1K /s/ Seth Levy Seth Levy, attorney-in-fact*